H0616B2760A07568 LKK:CMD 10/05/20 #90 A07568
AMENDMENTS TO HOUSE BILL NO. 616
Sponsor: SENATOR BAKER
Printer's No. 2760
Amend Bill, page 1, lines 14 through 17, by striking out all
of said lines and inserting
Section 1. Section 4(2)(ii) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended by adding a subclause and
the section is amended by adding a paragraph to read:
Amend Bill, page 2, by inserting between lines 17 and 18
(6) A drug product in a finished dosage formulation that
contains 2-[1R-3-methyl-6R-(1methylethenyl)-2-cyclohexen-1-yl]-
5-pentyl-1,3-benzenediol that has been approved by the Federal
Food and Drug Administration pursuant to section 505 of the
Federal Food, Drug and Cosmetic Act prior to the date of
enactment shall not be subject to control under this act.
2020/90LKK/HB0616A07568 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
See A07568 in
the context
of HB0616